Book contents
- EpilepsyA Global Approach
- Epilepsy
- Copyright page
- Dedication
- Contents
- Contributors
- Acknowledgments
- Section 1 Editorial Introduction
- Section 2 Infective Causes of Epilepsy
- Section 3 Consequences of Epilepsy
- Section 4 Comprehensive Epilepsy Care
- Section 5 The Medical Management of Epilepsy
- Section 6 The Surgical Management of Epilepsy
- Section 7 Non-Pharmacologic Management of Epilepsy
- Section 8 Epilepsy Issues with Global Health Impact
- Section 9 International Perspectives
- Index
- References
Section 8 - Epilepsy Issues with Global Health Impact
Published online by Cambridge University Press: 13 April 2017
Book contents
- EpilepsyA Global Approach
- Epilepsy
- Copyright page
- Dedication
- Contents
- Contributors
- Acknowledgments
- Section 1 Editorial Introduction
- Section 2 Infective Causes of Epilepsy
- Section 3 Consequences of Epilepsy
- Section 4 Comprehensive Epilepsy Care
- Section 5 The Medical Management of Epilepsy
- Section 6 The Surgical Management of Epilepsy
- Section 7 Non-Pharmacologic Management of Epilepsy
- Section 8 Epilepsy Issues with Global Health Impact
- Section 9 International Perspectives
- Index
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- EpilepsyA Global Approach, pp. 175 - 200Publisher: Cambridge University PressPrint publication year: 2017
References
References
Shorvon, S D, Farmer, P J. Epilepsy in developing countries: a review of epidemiological, sociocultural, and treatment aspects. Epilepsia 1988; 29(Suppl 1):S36–S54.CrossRefGoogle ScholarPubMed
Feksi, A T, Kaamugisha, J, Sander, J W A S, Gatiti, S, Shorvon, S D. Comprehensive primary health care antiepileptic drug treatment programme in rural and semi-urban Kenya. Lancet 1991; 337:406–09.Google Scholar
Placencia, M, Sander, J W A S, Shorvon, S D, et al. Antiepileptic drug treatment in a community health-care setting in northern Ecuador: a prospective 12-month assessment. Epilepsy Res 1993; 14:237–24.CrossRefGoogle Scholar
Aziz, H, Ali, S M, Frances, P, Khan, M I, Hasan, K Z. Epilepsy in Pakistan: a population-based epidemiologic study. Epilepsia 1994; 35:950–58.CrossRefGoogle ScholarPubMed
Coleman, R, Loppy, L, Walraven, G. The treatment gap and primary health care for people with epilepsy in rural Gambia. Bull World Health Organ 2002; 80:378–83.Google ScholarPubMed
Wang, W Z, Wu, J Z, Wang, D S, et al. The prevalence and treatment gap in epilepsy in China: an ILAE/IBE/WHO study. Neurology 2003; 60:1544–45.CrossRefGoogle Scholar
Mac, T L, Tran, D S, Quet, F, et al. Epidemiology, aetiology, and clinical management of epilepsy in Asia: a systematic review. Lancet Neurol 2007; 6(6):533–43.CrossRefGoogle ScholarPubMed
Ray, B K, Bhattacharya, S, Kundu, T N, et al. Epidemiology of epilepsy – Indian perspective. J Indian Med Assoc 2002; 100:322–26.Google ScholarPubMed
Aziz, H, Guvener, A, Akhtar, S W, et al. Comparative epidemiology of epilepsy in Pakistan and Turkey: population based studies using identical protocols. Epilepsia 1997; 38:716–22.Google Scholar
Sridharan, R, Murthy, B M. Prevalence and pattern of epilepsy in India. Epilepsia 1999; 40:631–36.Google Scholar
Gourie-Devi, M, Satishchandra, P, Gururaj, G. Epilepsy control program in India: a district model. Epilepsia 2003; 44:58–62.CrossRefGoogle ScholarPubMed
Pal, D K. Methodologic issues in assessing risk factors for epilepsy in an epidemiologic study in India. Neurology 1999; 53:2058–63.CrossRefGoogle Scholar
Mani, K S. Epidemiology of epilepsy in Karnataka, India. Neurosci Today 1997; 1:167–74.Google Scholar
Bharucha, N E, Weiss, M G, Bharucha, E P, et al. Sociocultural aspects of epilepsy in developing countries. Presented at the 22nd Epilepsy congress, Dublin, Ireland, July 1997.Google Scholar
Bharucha, N E, Bharucha, E P, Bharucha, A E, et al. Prevalence of epilepsy in the Parsi community of Bombay. Epilepsia 1998; 29:111–15.Google Scholar
Radhakrishnan, K, Pandian, J D, Santhoshkumar, T, et al. Prevalence, knowledge, attitude, and practice of epilepsy in Kerala, South India. Epilepsia 2000; 41:1027–35.CrossRefGoogle ScholarPubMed
Mbuba, C K, Ngugi, A K, Newton, C R, Carter, J A. The epilepsy treatment gap in developing countries: a systematic review of the magnitude, causes and intervention strategies. Epilepsia 2008; 49:1491–503.Google Scholar
Dent, W, Helbok, R, Matuja, W B, Scheunemann, S, Schmutzhard, E. Prevalence of active epilepsy in a rural area in South Tanzania: a door-to-door survey. Epilepsia 2005; 46:1963–69.Google Scholar
Mendizabal, J E, Salguero, L F. Prevalence of epilepsy in a rural community of Guatemala. Epilepsia 1996; 37:373–76.Google Scholar
Medina, M T, Duron, R M, Martinez, L, et al. Prevalence, incidence, and etiology of epilepsies in rural Honduras: the Salama study. Epilepsia 2005; 46:124–31.Google Scholar
Ndoye, N F, Sow, A D, Diop, A G, et al. Prevalence of epilepsy its treatment gap and knowledge, attitude and practice of its population in sub-urban Senegal an ILAE/IBE/WHO study. Seizure 2005; 14:106–11.Google Scholar
Nicoletti, A, Reggio, A, Bartoloni, A, et al. Prevalence of epilepsy in rural Bolivia: a door-to-door survey. Neurology 1999; 53:2064–69.CrossRefGoogle ScholarPubMed
Noronha, A L, Marques, L H, Borges, M A, et al. Assessment of the epilepsy treatment gap in two cities of south-east of Brazil. Arq Neuropsiquiatr 2004; 62(3B):761–63.Google Scholar
Noronha, A L, Borges, M A, Marques, L H, et al. Prevalence and pattern of epilepsy treatment in different socioeconomic classes in Brazil. Epilepsia 2007; 48:880–85.Google Scholar
Somoza, M J, Forlenza, R H, Brussino, M, Liliana, L. Epidemiological survey of epilepsy in the primary school population in Buenos Aires. Neuroepidemiology 2005; 25:62–68.CrossRefGoogle ScholarPubMed
Reynolds, E H. The ILAE/IBE/WHO Global Campaign against Epilepsy: bringing epilepsy “out of the shadows”. Epilepsy Behav 2000; 1:S3–S8.Google Scholar
Meinardi, H, Scott, R A, Reis, R, Sander, J W. The treatment gap in epilepsy: the current situation and ways forward. Epilepsia 2001; 42:136–49.Google Scholar
Wang, W, Wu, J, Dai, X, et al. Global campaign against epilepsy: assessment of a demonstration project in rural China. Bull World Health Organ 2008; 86(12):964–69.Google ScholarPubMed
References
Carpio, A, Hauser, W A. Epilepsy in the developing world. Curr Neurol Neurosci Rep. 2009; 9(4):319–26.Google Scholar
Banerjee, P N, Filippi, D, Hauser, W A. The descriptive epidemiology of epilepsy – a review. Epilepsy Res. 2009;85(1):31–45.CrossRefGoogle ScholarPubMed
Aziz, H, Güvener, A, Akhtar, S W, Hasan, K Z. Comparative epidemiology of epilepsy in Pakistan and Turkey: population‐based studies using identical protocols. Epilepsia. 1997;38(6):716–22.Google Scholar
Rwiza, H T, Kilonzo, G P, Haule, J, et al. Prevalence and incidence of epilepsy in Ulanga, a rural Tanzanian district: a community‐based study. Epilepsia. 1992;33(6):1051–56.Google Scholar
Birbeck, G L, Kalichi, E. Epilepsy prevalence in rural Zambia: a door‐to‐door survey. Trop Med Int Health. 2004;9(1):92–95.Google Scholar
Nicoletti, A, Reggio, A, Bartoloni, A, et al. Prevalence of epilepsy in rural Bolivia. A door-to-door survey. Neurology. 1999;53(9):2064.CrossRefGoogle ScholarPubMed
Medina, M, Rosas, E, Rubio, F, et al. Neurocysticercosis as the main cause of late-onset epilepsy in Mexico. Arch Intern Med. 1990;150:325–27.Google Scholar
Garcia-Noval, J, Allan, J C, Fletes, C. Epidemiology of Taenia solium taeniasis and cysticercosis in two rural Guatemalan communities. Am J Trop Med Hyg. 1996;55(3):282–89.Google Scholar
Medina, M T, Durón, R M, Martínez, L, et al. Prevalence, incidence, and etiology of epilepsies in rural Honduras: the Salama Study. Epilepsia. 2005;46(1):124–31.CrossRefGoogle ScholarPubMed
Ngugi, A K, Bottomley, C, Kleinschmidt, I, et al. Prevalence of active convulsive epilepsy in sub-Saharan Africa and associated risk factors: cross-sectional and case-control studies. Lancet Neurol. 2013;12(3):253–63.CrossRefGoogle ScholarPubMed
Pal, D K, Carpio, A, Sander, J W. Neurocysticercosis and epilepsy in developing countries. J Neurol Neurosurg Psychiatry. 2000;68(2):137–43.Google Scholar
Thapa, A, Chandra, S P, Sinha, S, et al. Post-traumatic seizures – a prospective study from a tertiary level trauma center in a developing country. Seizure. 2010;19(4):211–16.CrossRefGoogle ScholarPubMed
Luciano, A L, Shorvon, S D. Results of treatment changes in patients with apparently drug-resistant chronic epilepsy. Ann Neurol. 2007;62(4):375–81.CrossRefGoogle ScholarPubMed
Kwan, P, Schachter, S C, Brodie, M J. Drug-resistant epilepsy. New Engl J Med. 2011;365(10).CrossRefGoogle ScholarPubMed
Callaghan, B, Schlesinger, M, Rodemer, W, et al. Remission and relapse in a drug-resistant epilepsy population followed prospectively. Epilepsia. 2011;52:619–26.Google Scholar
Kariuki, S M, Matuja, W, Akpalu, A, et al. Clinical features, proximate causes, and consequences of active convulsive epilepsy in Africa. Epilepsia. 2014;55(1):76–85.CrossRefGoogle ScholarPubMed
Birbeck, G, Chomba, E, Atadzhanov, M, et al. The social and economic impact of epilepsy in Zambia: a cross-sectional study. Lancet Neurol. 2007;6(1):39–44.Google Scholar
Munyoki, G, Edwards, T, White, S, et al. Clinical and neurophysiologic features of active convulsive epilepsy in rural Kenya: a population‐based study. Epilepsia. 2010;51(12):2370–76.CrossRefGoogle ScholarPubMed
Mbodj, I, Ndiaye, M, Sene, F, et al. Treatment of status epilepticus in a developing country. Neurophysiol Clin. 2000;30(3):165–69.Google ScholarPubMed
Forsgren, L, Hauser, WA, Olafsson, E, et al. Mortality of epilepsy in developed countries: a review. Epilepsia. 2005;46(Suppl 11):18–27.Google Scholar
Callaghan, B, Choi, H, Schlesinger, M. Increased mortality persists in an adult drug-resistant epilepsy prevalence cohort. J Neurol Neurosurg Psychiatry. 2014;85:1084–90.Google Scholar
Diop, AG, Hesdorffer, DC, Logroscino, G, Hauser, W A. Epilepsy and mortality in Africa: a review of the literature. Epilepsia. 2005;46(Suppl 11):33–35.CrossRefGoogle Scholar
Kamgno, J, Pion, S D, Boussinesq, M. Demographic impact of epilepsy in Africa: results of a 10-year cohort study in a rural area of Cameroon. Epilepsia. 2003;44(7):956–63.Google Scholar
Thomas, S V, Reghunath, B, Sankara Sarma, P. Mortality among epilepsy patients attending a tertiary referral center in a developing country. Seizure. 2001;10(5):370–73.Google Scholar
Berg, A T. Identification of pharmacoresistant epilepsy. Neurol Clin. 2009;27(4):1003–13.Google Scholar
Kwan, P, Arzimanoglou, A, Brodie, M J, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2010;51(6):1069–77.Google Scholar
Guinhouya, K M, Aboki, A, Kombaté, D, et al. [The epilepsy treatment gap in six primary care centres in Togo (2007–2009)]. Sante. 2010;20(2):93–7.Google Scholar
Lomidze, G, Kasradze, S, Kvernadze, D, et al. The prevalence and treatment gap of epilepsy in Tbilisi, Georgia. Epilepsy Res. 2012;98(2–3):123–29.CrossRefGoogle ScholarPubMed
Meyer, AC, Dua, T, Ma, J, Saxena, S, Birbeck, G. Global disparities in the epilepsy treatment gap: a systematic review. Bull World Health Org. 2010;88(4):260–66.Google Scholar
Neligan, A, Bell, G S, Elsayed, M, Sander, J W, Shorvon, S D. Treatment changes in a cohort of people with apparently drug-resistant epilepsy: an extended follow-up. J Neurol Neurosurg Psychiatry. 2012;83(8):810–13.Google Scholar
Brodie, M J, Barry, S J, Bamagous, G A, Kwan, P. Effect of dosage failed of first antiepileptic drug on subsequent outcome. Epilepsia. 2013;54(1):194–98.CrossRefGoogle ScholarPubMed
Hao, X, Goldberg, D, Kelly, K, et al. Uncontrolled epilepsy is not necessarily the same as drug-resistant epilepsy: differences between populations with newly diagnosed epilepsy and chronic epilepsy. Epilepsy Behav. 2013;29(1):4–6.Google Scholar
Kwan, P, Brodie, M J. Early identification of refractory epilepsy. New Engl J Med. 2000; 342(5):314–19.Google Scholar
Radhakrishnan, K, So, E L, Silbert, P L, et al. Prognostic implications of seizure recurrence in the first year after anterior temporal lobectomy. Epilepsia. 2003;44(1):77–80.Google Scholar
Boling, W, Palade, A, Wabulya, A, et al. Surgery for pharmacoresistant epilepsy in the developing world: a pilot study. Epilepsia. 2009;50(5):1256–61.Google Scholar
Wu, X T, Li, L, Yan, B, et al. How to effectively constrain the cost of presurgical evaluation for resective surgery in low-income population: clinically oriented opinions. Seizure. 2011;20(5):425–27.CrossRefGoogle ScholarPubMed
References
Alarcon, G, Nashef, L, Cross, H, Nightingale, J, Richardson, S. Epilepsy. Oxford Specialist Handbooks in Neurology. Oxford: Oxford University Press, 2009: Chapter 3.Google Scholar
De Boer, H M, Mula, M, Sander, J. The global burden and stigma of epilepsy. Epilepsy and Behaviour 2008; 12: 540–546.Google Scholar
Beavis, J, Kerr, M, Marson, A G. Pharmacological interventions for epilepsy in people with Intellectual Disabilities. Cochrane Database System Review 2007;(3):CD005399.Google Scholar
Durkin, M. The epidemiology of developmental disabilities in low income countries. Mental Retardation and Developmental Disabilities Research Reviews 2002; 8:206–07.Google Scholar
Senanayake, N, Roman, G C. Epidemiology of epilepsy in developing countries. Bulletin of the World Health Organization 1993;71(2):247–58.Google Scholar
Chiba, Y, Shimada, A, Yoshida, F, et al. Risk of fall for individuals with intellectual disability. American Journal of Intellectual Developmental Disabilities 2009; 111(4):225–236.Google Scholar
Buono, S, Scannella, F, Palmigiano, M, et al. Self-injury in people with intellectual disability and epilepsy: a matched control study. Seizure 2012;21:160–64.Google Scholar
Kerr, M, Turky, A, Huber, B. The psychosocial impact of epilepsy in adults with an intellectual disability. Epilepsy and Behaviour 2009;15:S26–S30.Google Scholar
Matthews, T, Weston, N, Baxter, H, Felce, D, Kerr, M. A general practice-based prevalence study of epilepsy among adults with intellectual disabilities and of its association with psychiatric disorder, behaviour disturbance and carer stress. Journal of Intellectual Disability Research 2008;52:163–73.Google Scholar
Turky, A, Felce, D, Jones, G, Kerr, M. A prospective case control study of psychiatric disorders in adults with epilepsy and intellectual disability. Epilepsia 2011;52(7):1223–30.CrossRefGoogle ScholarPubMed
Morgan, C, Scheepers, M, Kerr, M. Mortality in patients with intellectual disability and epilepsy. Psychiatry 2001;14:471–73.Google Scholar
Kiani, R, Tyrer, F, Jesu, A, et al. Mortality from sudden unexpected death in epilepsy (SUDEP) in a cohort of adults with intellectual disability. Journal of Intellectual Disability Research 2014;58:508–20.CrossRefGoogle Scholar
Collacott, R. Epilepsy, dementia and adaptive behaviour in Down’s syndrome. Journal of Intellectual Disability Research 1993;37:153–60.CrossRefGoogle ScholarPubMed
De Simone, R, Puig, XS, Gelisse, P, Crespel, A, Genton, P. Senile myoclonic epilepsy: delineation of a common condition associated with Alzheimer's disease in Down syndrome. Seizure 2010;19:383–89.Google Scholar
Chapman, M, Iddon, P, Atkinson, K, et al. The misdiagnosis of epilepsy in people with intellectual disabilities: a systematic review. Seizure 2011;20:101–06.CrossRefGoogle ScholarPubMed
Chowdhury, F, Nashef, L, Elwes, R. Misdiagnosis in epilepsy: a review and recognition of diagnostic uncertainty. European Journal of Neurology 2008;15;1038–39.Google Scholar
Kerr, M, Gil-Nagel, A, Glynn, M, et al. Treatment of behavioural problems in intellectually disabled adult patients with epilepsy. Epilepsia 2013;54(Suppl 1):34–40.Google Scholar
Hancock, E C, Cross, J H. Treatment of Lennox–Gastaut syndrome. Cochrane Database of Systematic Reviews 2013;(2):CD003277.Google ScholarPubMed
World Health Organization. mhGAP Intervention Guide for mental, neurological and substance use disorders in non-specialised health settings. Geneva: World Health Organization, 2010; 37.Google Scholar
Kerr, M P, Guidelines Working Group Consensus. Guidelines into the management of epilepsy in adults with an intellectual disability. Journal of Intellectual Disability Research 2009;53:687–94.Google Scholar
Turner, S. Increasing health checks for people with learning disabilities. Nursing Standard 2011;26(7):35–38.Google Scholar
Bouras, N. Mental health problems and related issues for people with developmental and intellectual disability. Current Opinion in Psychiatry 2011;24;365–66.Google Scholar
Schwartz, C E, Neri, G. Autism and intellectual disability: two sides of the same coin. American Journal of Medical Genetics Part C Seminars in Medical Genetics 2012;160C(2):89–90CrossRefGoogle ScholarPubMed
Mukhopadhyay, A, Harsha, G, Costa, E, Anderton, S, Karki, C. A survey of carers’ views on the use of rescue medication in people with intellectual disability having prolonged seizures: are the winds of change blowing? The British Journal of Developmental Disabilities 2010;56(part 1): 11–18.CrossRefGoogle Scholar
References
Accessed November 29, 2012, at: http://old.epilepsyfoundation.org/living/wellness/transportation/airtravel.cfm#.ULA6h6WHSq4Google Scholar
Accessed November 29, 2012, at: http://epilepsy.med.nyu.edu/living-with-epilepsy/epilepsy-and-lifestyle/health-insurance-epilepsy.Google Scholar
Beghi, E, Brown, S, Capurro, D, et al. IBE Commission Report. 2nd Workshop on ‘‘epilepsy, risks, and insurance.” Epilepsia 2000;41:110–12.Google Scholar
Ooi, W W, Gutrecht, J A. International regulations for automobile driving and epilepsy. Journal of Travel Medicine 2000;7(1):1–4.Google Scholar
Inoue, Y, Ito, M, Kurihara, M, Morimoto, K, Commission on Legal Affairs, Japan Epilepsy Society (Japan chapter of ILAE). Epilepsy and driving in Japan. Epilepsia 2004;45(12):1630–35.Google Scholar
Krauss, G L, Ampaw, L, Krumholz, A. Individual state driving restrictions for people with epilepsy in the US. Neurology 2001;57(10):1780–85.Google Scholar
Drazkowski, J F, Fisher, R S, Sirven, J I, et al. Seizure-related motor vehicle crashes in Arizona before and after reducing the driving restriction from 12 to 3 months. Mayo Clinic Proceedings 2003;78:819–25.Google Scholar
Devlin, A L, Odell, M, Charlton, J L, Koppel, S. Epilepsy and driving: current status of research. Epilepsy Research 2012;102(3):135–52.CrossRefGoogle Scholar
Lossius, R, Kinge, E, Nakken, K O. Epilepsy and driving: considerations on how eligibility should be decided. Acta Neurologica Scandinavica Supplement 2010;190:67–71.Google Scholar
Wortzel, H S, Strom, L A, Anderson, A C, Maa, E H, Spitz, M. Disrobing associated with epileptic seizures and forensic implications. Journal of Forensic Sciences 2012;57(2):550–52.Google Scholar
Treiman, D M. Epilepsy and violence: medical and legal issues. Epilepsia 1986;27(Suppl 2):S77–S104.Google Scholar
Shih, J J, LeslieMazwi, T, Falcao, G, Van Gerpen, J. Directed aggressive behavior in frontal lobe epilepsy: a video-EEG and ictal SPECT case study. Neurology 2009;73(21):1804–06.Google Scholar
Reuber, M, Mackay, R D. Epileptic automatisms in the criminal courts: 13 cases tried in England and Wales between 1975 and 2001. Epilepsia 2008;49(1):138–45.Google Scholar
Falk-Pedersen, J K. Automatisms in non common law countries. Medicine and Law 1997;16(2):359–65.Google ScholarPubMed
Finucane, A K. Legal issues in neurology and pregnancy. The physician’s duty of care. Neurology Clinics 1994;12(3):637–53.Google Scholar
Coker, M F, Bhargava, S, Fitzgerald, M, Doherty, C P. What do people with epilepsy know about their condition? Evaluation of a subspecialty clinic population. Seizure 2011;20(1):55–59.Google Scholar
Accessed November 29, 2012, at: www.hhs.gov/ocr/privacy/hipaa/administrative/statute/index.htmlGoogle Scholar
Freedman, B. The personal health protection act, 2004: Ontario response to PIPEDA. Health Law Canada 2004;24(4):84–94.Google Scholar
Shostak, S, Ottman, R. Ethical, legal, and social dimensions of epilepsy genetics. Epilepsia 2006;47(10):1595–602.Google Scholar
Further Reading
References
Reynolds, E H. The ILAE/IBE/WHO Global Campaign history: In Epilepsy in the World Launch of the second phase of the ILAE/IBE/WHO Global Campaign Against Epilepsy. Epilepsia 2002;43(Suppl 6):S9–S11.Google Scholar
De Boer, H M. “Out of the shadows”: a global campaign against epilepsy. Epilepsia 2002;43(Suppl 6):7–8.Google Scholar
Global Campaign Against Epilepsy 2001: Annual Report. Geneva: International League against Epilepsy, International Bureau for Epilepsy & WHO, 2002.Google Scholar
Meinardi, H, Scott, R A, Reis, R, et al. The treatment gap in epilepsy. Epilepsia 2001;42:136–49.Google Scholar
Li, S C. A report of the feasibility test for “Community Control of Epilepsy” proposed by WHO. Chinese Journal of Neurology and Psychiatry 1989:22:144–47 [Chinese].Google Scholar
References
Mbuba, C K, Ngugi, A K, Newton, C R, Carter, J A. The epilepsy treatment gap in developing countries: a systematic review of the magnitude, causes, and intervention strategies. Epilepsia. 2008;49(9):1491–503.Google Scholar
Kwan, P, Arzimanoglou, A, Berg, A T, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2010;51(6):1069–77.CrossRefGoogle Scholar